Chemical Strategies to Enhance Antisense Strand Selection and Minimize Off-Target Effect-Mediated by siRNAs
Anne Mobergslien1, Mouldy Sioud2
1Division of Cancer Medicine, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Abstract:
Small interfering RNAs (siRNAs) hold significant promise as therapeutic agents for treating human diseases. However, their use is often limited by unintended off-target effects arising from both the sense and antisense strands. Since the 5'-phosphate group on either strand is necessary for recognition by Argonaute 2 (AGO2), the core protein in the RNA-induced silencing complex (RISC), blocking phosphorylation of the sense strand may prevent its incorporation into RISC, thereby reducing potential off-target effects. In this chapter, we describe the use of biotin, a naturally occurring compound, to block 5'-end phosphorylation on either the sense or antisense strand to prevent their selection by AGO2. This strategy should offer a practical option to enhance siRNA specificity and efficacy.
More Related Videos
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Small interfering RNAs (siRNA)


